These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 7063289

  • 1. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC, Dine MS, Roselle GA, Askey PA.
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [Abstract] [Full Text] [Related]

  • 2. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE, Nalin DR, Chui LW, Whitwell J, Marusyk RG, Kumar ML.
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [Abstract] [Full Text] [Related]

  • 3. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC, Orenstein WA, Bernier RH, Herrmann KL, Sirotkin B, Hopfensperger D, Schuh R, Albrecht P, Lievens AW, Brunell PA.
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [Abstract] [Full Text] [Related]

  • 4. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children.
    Arpadi SM, Markowitz LE, Baughman AL, Shah K, Adam H, Wiznia A, Lambert G, Dobroszycki J, Heath JL, Bellini WJ.
    Pediatrics; 1996 May; 97(5):653-7. PubMed ID: 8628602
    [Abstract] [Full Text] [Related]

  • 5. Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination.
    Bertley FM, Ibrahim SA, Libman M, Ward BJ.
    Vaccine; 2004 Dec 09; 23(4):444-9. PubMed ID: 15530692
    [Abstract] [Full Text] [Related]

  • 6. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM.
    J Infect Dis; 2004 Jul 01; 190(1):83-90. PubMed ID: 15195246
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
    de Serres G, Boulianne N, Ratnam S, Corriveau A.
    Pediatrics; 1996 Feb 01; 97(2):232-5. PubMed ID: 8584383
    [Abstract] [Full Text] [Related]

  • 8. The role of herd immunity in control of measles.
    Black FL.
    Yale J Biol Med; 1982 Feb 01; 55(3-4):351-60. PubMed ID: 7180027
    [Abstract] [Full Text] [Related]

  • 9. Revaccination against measles--a pilot study.
    Watson GI, Nichols JA, Robshaw JR.
    J R Coll Gen Pract; 1975 Dec 01; 25(161):863-73. PubMed ID: 1223275
    [Abstract] [Full Text] [Related]

  • 10. Antibody response after measles immunization.
    Ariyasriwatana C, Kalayanarooj S, Pattamadilok S.
    J Med Assoc Thai; 2003 Aug 01; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [Abstract] [Full Text] [Related]

  • 11. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N, Uzel N, Gökçay G, Kiliç A, Yilmaz G, Sadikoğlu B, Diri S.
    Pediatr Infect Dis J; 2003 Aug 01; 22(8):691-5. PubMed ID: 12913768
    [Abstract] [Full Text] [Related]

  • 12. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team.
    Markowitz LE, Albrecht P, Rhodes P, Demonteverde R, Swint E, Maes EF, Powell C, Patriarca PA.
    Pediatrics; 1996 Jan 01; 97(1):53-8. PubMed ID: 8545224
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL.
    Vaccine; 2006 Jan 30; 24(5):683-90. PubMed ID: 16154241
    [Abstract] [Full Text] [Related]

  • 14. Inadequate immunity to measles in children vaccinated at an early age: effect of revaccination.
    Black FL, Berman LL, Libel M, Reichelt CA, Pinheiro FD, Travassos da Rosa A, Figueira F, Siqueira Gonzales E.
    Bull World Health Organ; 1984 Jan 30; 62(2):315-9. PubMed ID: 6610499
    [Abstract] [Full Text] [Related]

  • 15. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK, Singhal PK, Khare S, Kumari S, Mathur R, Mullick DN.
    Indian Pediatr; 1989 Aug 30; 26(8):765-72. PubMed ID: 2620977
    [Abstract] [Full Text] [Related]

  • 16. Measles vaccine efficacy in children previously vaccinated at 12 months of age.
    Marks JS, Halpin TJ, Orenstein WA.
    Pediatrics; 1978 Dec 30; 62(6):955-60. PubMed ID: 733423
    [Abstract] [Full Text] [Related]

  • 17. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
    Ueda K, Hashiguchi K, Nakashima F, Ueda S, Takahashi M.
    Biken J; 1981 Sep 30; 24(3):119-22. PubMed ID: 7337678
    [Abstract] [Full Text] [Related]

  • 18. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
    Yuan L.
    CMAJ; 1994 Apr 01; 150(7):1093-8. PubMed ID: 8137189
    [Abstract] [Full Text] [Related]

  • 19. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH, Lee CY, Chih TW, Lee PI, Chang LY, Lin YJ, Hsu CM, Huang LM.
    J Med Virol; 1997 Jan 01; 51(1):32-5. PubMed ID: 8986946
    [Abstract] [Full Text] [Related]

  • 20. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.
    Wong-Chew RM, Beeler JA, Audet S, Santos JI.
    J Med Virol; 2003 Jun 01; 70(2):276-80. PubMed ID: 12696117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.